Celsion to Present Two Posters with Data of GEN-1 in Ovarian Cancer at ASCO Meeting

Celsion to Present Two Posters with Data of GEN-1 in Ovarian Cancer at ASCO Meeting
Celsion Corporation will present two posters with key findings of its IL-12 gene-mediated immunotherapy, GEN-1, in ovarian cancer. The presentations will be made at the American Society of Clinical Oncology (ASCO) – Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium in Orlando, Fla., Feb. 23-25. The first poster, titled “Phase I study and activity of

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *